Charles Pauling Semba - Jul 15, 2021 Form 3 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role
Director
Signature
/s/ Amy Culbert, attorney-in-fact
Stock symbol
DMAC
Transactions as of
Jul 15, 2021
Transactions value $
$0
Form type
3
Date filed
7/16/2021, 04:16 PM
Next filing
Jun 2, 2022

No securities are beneficially owned.